According to the ACMG guidelines, we identified two novel “likely pathogenic” mutations and 11 variants of uncertain significance (VUS) in the GSN gene, two VUS in the CST3 gene, two VUS in the ITM2B gene, and two VUS in the TTR gene in patients with AD in the Chinese cohort (Table 2). The gene discussed is CST3; the disease is Alzheimer disease.